Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

4D robust optimization including uncertainties in time structures can reduce the interplay effect in proton pencil beam scanning radiation therapy

09/09/2018
/ Publications
/
Clinical Trial
Pencil Beam Scanning - PBS

Interplay effects in PB-PT, can be reduced by generating "time structures" that align to different time-points of the breathing cycle, delivering accurately the...

Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma

30/05/2016
/ Publications
/
Clinical Trial

A randomized trial comparing proton therapy with transarterial chemoembolization (TACE) for hepatocellular carcinoma, reported a trend toward improved local...

The State of Proton Therapy in the U.S.

14/09/2022
/ Webinar
/
Clinical Trial
Proton therapy center
Chemotherapy

During ISOP 2022, James Mets presented The State of Proton Therapy in the U.S. Watch the webinar above.

Expanding Proton Therapy to Community Oncology Practices

14/09/2022
/ Webinar
/
Clinical Trial

During ISOP 2022, Barbara McAneny how to expand Proton Therapy to Community Oncology Practices. Watch the webinar above.

Proton Beam Therapy for Esophageal Cancer.

15/11/2022
/ Publications
/
Clinical Trial

A latest review examined the existing of PBT for locally advanced esophageal cancer, including dosimetric comparative studies, early clinical outcome...

Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial.

05/09/2023
/ Publications
/
Clinical Trial

Published by the Loma Linda group, this study reported the results of their randomized trial compared PBT with TACE for HCC. Patients were randomized to receive...

Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.

16/07/2021
/ Publications
/
Clinical Trial

Thirty patients with caudate lobe HCC were treated to a total doses of 55 to 77 (median 72.6) GyRBE. The median follow-up period was 37.5 months. The OS rates...

Proton versus photon radiation therapy: A clinical review.

16/03/2023
/ Publications
/
Clinical Trial

This review summarized comparative clinical outcomes between proton and photon radiotherapy. 63 interventional comparative studies were presented in this...

Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT)

05/06/2024
/ Publications
/
Clinical Trial

Patients (n=440) were randomized to undergo IMRT(n=219) or IMPT (n=221) at 21 institutions. The median age was 61 years and HPV/p16 was positive in 95%. IC was...

An Interview with Dr. Steven Frank

17/07/2024
/ Webinar
/
Clinical Trial

Learn from Dr. Steven Frank as he discusses the results, challenges, and implications of the study "Phase III randomized trial of intensity-modulated proton...